Steve S. Carroll

427 total citations
12 papers, 288 citations indexed

About

Steve S. Carroll is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Steve S. Carroll has authored 12 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 6 papers in Molecular Biology and 4 papers in Virology. Recurrent topics in Steve S. Carroll's work include HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (4 papers) and Hepatitis C virus research (3 papers). Steve S. Carroll is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (4 papers) and Hepatitis C virus research (3 papers). Steve S. Carroll collaborates with scholars based in United States, United Kingdom and Canada. Steve S. Carroll's co-authors include David B. Olsen, Jules A. Shafer, Lawrence C. Kuo, Donald J. Graham, Joseph Culberson, Carl D. Bennett, Andrew M. Stern, Jon H. Condra, Daria J. Hazuda and L Gotlib and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Steve S. Carroll

12 papers receiving 281 citations

Peers

Steve S. Carroll
Joan Zugay-Murphy United States
Akhter Molla United States
Jared Lindenberger United States
Lili Hu China
Oliver L. Saunders United States
Yasushi Tojo Japan
Monica Donghi Italy
Carlo Boutton Belgium
Steven R. Mathieu United States
Christopher J. Yarnold United Kingdom
Joan Zugay-Murphy United States
Steve S. Carroll
Citations per year, relative to Steve S. Carroll Steve S. Carroll (= 1×) peers Joan Zugay-Murphy

Countries citing papers authored by Steve S. Carroll

Since Specialization
Citations

This map shows the geographic impact of Steve S. Carroll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve S. Carroll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve S. Carroll more than expected).

Fields of papers citing papers by Steve S. Carroll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve S. Carroll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve S. Carroll. The network helps show where Steve S. Carroll may publish in the future.

Co-authorship network of co-authors of Steve S. Carroll

This figure shows the co-authorship network connecting the top 25 collaborators of Steve S. Carroll. A scholar is included among the top collaborators of Steve S. Carroll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve S. Carroll. Steve S. Carroll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
He, Xi, Shuo Quan, Min Xu, et al.. (2021). Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing. Proceedings of the National Academy of Sciences. 118(15). 58 indexed citations
2.
Liu, Jian, Younong Yu, Joseph Kelly, et al.. (2020). Discovery of Highly Selective and Potent HDAC3 Inhibitors Based on a 2-Substituted Benzamide Zinc Binding Group. ACS Medicinal Chemistry Letters. 11(12). 2476–2483. 38 indexed citations
3.
Liu, Jian, Joseph Kelly, Wensheng Yu, et al.. (2020). Selective Class I HDAC Inhibitors Based on Aryl Ketone Zinc Binding Induce HIV-1 Protein for Clearance. ACS Medicinal Chemistry Letters. 11(7). 1476–1483. 25 indexed citations
4.
Chase, Robert A., Stephanie Curry, Min Xu, et al.. (2016). Lack of Interaction Between Elbasvir/Grazoprevir and Approved HIV and Hepatitis B Virus Drugs in Viral Replication In Vitro. Open Forum Infectious Diseases. 3(suppl_1). 1 indexed citations
5.
Lemaire, Peter A., Lingyi Huang, Ya Zhuo, et al.. (2014). Chondroitin Sulfate Promotes Activation of Cathepsin K. Journal of Biological Chemistry. 289(31). 21562–21572. 19 indexed citations
6.
Burlein, Christine, et al.. (2014). Development of a sensitive amplified luminescent proximity homogeneous assay to monitor the interactions between pTEFb and Tat. Analytical Biochemistry. 465. 164–171. 4 indexed citations
7.
Carroll, Steve S., John A. McCauley, Paul J. Coleman, et al.. (2010). MK-5172, a Novel Macrocyclic Inhibitor of NS3/4a Protease Demonstrates Efficacy Against Viral Resistance in the Chimpanzee Model of Chronic Hepatitis C Virus Infection. Antiviral Research. 86(1). A21–A21. 1 indexed citations
8.
Ontoria, Jesus M., Edwin H. Rydberg, Stefania Di Marco, et al.. (2009). Identification and Biological Evaluation of a Series of 1H-Benzo[de]isoquinoline-1,3(2H)-diones as Hepatitis C Virus NS5B Polymerase Inhibitors. Journal of Medicinal Chemistry. 52(16). 5217–5227. 40 indexed citations
9.
Olsen, David B., Steve S. Carroll, L K Handt, et al.. (2007). [791] HCV ANTIVIRAL ACTIVITY AND RESISTANCE ANALYSIS IN CHRONICALLY INFECTED CHIMPANZEES TREATED WITH NS3/4A PROTEASE AND NS5B POLYMERASE INHIBITORS. Journal of Hepatology. 46. S298–S298. 12 indexed citations
10.
Carroll, Steve S., Mark W. Stahlhut, James Geib, & David B. Olsen. (1994). Inhibition of HIV-1 reverse transcriptase by a quinazolinone and comparison with inhibition by pyridinones. Differences in the rates of inhibitor binding and in synergistic inhibition with nucleoside analogs.. Journal of Biological Chemistry. 269(51). 32351–32357. 17 indexed citations
11.
Carroll, Steve S., et al.. (1994). Effect of template secondary structure on the inhibition of HIV-1 reverse transcriptase by a pyridinone non-nucleoside inhibitor. Nucleic Acids Research. 22(8). 1437–1443. 32 indexed citations
12.
Carroll, Steve S., David B. Olsen, Carl D. Bennett, et al.. (1993). Inhibition of HIV-1 reverse transcriptase by pyridinone derivatives. Potency, binding characteristics, and effect of template sequence.. Journal of Biological Chemistry. 268(1). 276–281. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joan Zugay-Murphy Breakdown of academic impact, for papers by Akhter Molla Breakdown of academic impact, for papers by Jared Lindenberger Breakdown of academic impact, for papers by Lili Hu Breakdown of academic impact, for papers by Oliver L. Saunders Breakdown of academic impact, for papers by Yasushi Tojo Breakdown of academic impact, for papers by Monica Donghi Breakdown of academic impact, for papers by Carlo Boutton Breakdown of academic impact, for papers by Steven R. Mathieu Breakdown of academic impact, for papers by Christopher J. Yarnold
Rankless by CCL
2026